REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6

被引：0
|
作者：
Tuttle, Katherine [1 ,2 ]
Cherney, David [3 ]
Hadjadj, Samy [4 ]
Idorn, Thomas [5 ]
Mosenzon, Ofri [6 ]
Perkovic, Vlado [7 ]
Rasmussen, Soren [5 ]
Wolthers, Benjamin [5 ]
Bain, Stephen C. [8 ]
机构：
[1] Univ Washington, PMRC, Inst Translat Hlth Sci, Spokane, WA USA
[2] Nephrol Div, Spokane, WA USA
[3] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[4] Univ Nantes, CNRS, CHU Nantes, Inst Thorax,INSERM, Nantes, France
[5] Novo Nordisk, Soborg, Denmark
[6] Hadassah Hebrew Univ Hosp, Diabet Clin Res Ctr, Jerusalem, Israel
[7] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[8] Swansea Univ, Diabet Res Unit Cymru, Sch Med, Swansea, W Glam, Wales
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
TO002
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS
    Tuttle, Katherine
    Cherney, David
    Hadjadj, Samy
    Idorn, Thomas
    Mosenzon, Ofri
    Perkovic, Vlado
    Rasmussen, Soren
    Wolthers, Benjamin
    Bain, Stephen C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 152 - 152
  • [2] Cardiovascular, Metabolic and Safety Outcomes With Semaglutide by Age: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Petrie, Mark
    Bain, Stephen
    Hoff, Soren Tetens
    Johansen, Nicklas
    Rasmussen, Soren
    Vilsboell, Tina
    Husain, Mansoor
    CIRCULATION, 2021, 144
  • [3] Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Stephen C. Bain
    Nicolas Belmar
    Søren T. Hoff
    Mansoor Husain
    Søren Rasmussen
    Tina Vilsbøll
    Mark C. Petrie
    Diabetes Therapy, 2025, 16 (1) : 15 - 28
  • [4] Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Mellbin, L. G.
    Bhatt, D. L.
    David, J. -P.
    Petrie, M. C.
    Rasmussen, S.
    Schytz, P. A.
    Vilsboll, T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S304 - S305
  • [5] Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Cherney, David
    Bosch-Traberg, Heidrun
    Hadjadj, Samy
    Kuhlman, Anja B.
    Rasmussen, Soren
    Tuttle, Katherine R.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [6] Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
    Husain, Mansoor
    Consoli, Agostino
    De Remigis, Alessandra
    Meyer, Anna Sina Pettersson
    Rasmussen, Soren
    Bain, Stephen
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [7] Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
    Strain, W. David
    Frenkel, Ofir
    James, Martin A.
    Leiter, Lawrence A.
    Rasmussen, Soren
    Rothwell, Peter M.
    Ripa, Maria Sejersten
    Truelsen, Thomas C.
    Husain, Mansoor
    STROKE, 2022, 53 (09) : 2749 - 2757
  • [8] Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
    Mansoor Husain
    Agostino Consoli
    Alessandra De Remigis
    Anna Sina Pettersson Meyer
    Søren Rasmussen
    Stephen Bain
    Cardiovascular Diabetology, 21
  • [9] SEMAGLUTIDE REDUCED CARDIOVASCULAR EVENTS REGARDLESS OF METFORMIN USE: A POST HOC EXPLORATORY SUBGROUP ANALYSIS OF SUSTAIN 6 AND PIONEER 6
    Husain, Mansoor
    Consoli, Agostino
    De Remigis, Alessandra
    Meyer, Anna Sina
    Rasmussen, Soren
    Bain, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1604 - 1604
  • [10] Semaglutide reduced cardiovascular events regardless of metformin use: a post hoc exploratory subgroup analysis of SUSTAIN 6 and PIONEER
    Husain, M.
    Consoli, A.
    De Remigis, A.
    Meyer, A. S. P.
    Rasmussen, S.
    Bain, S.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 14 - 14
12345